(Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial.
about
Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer.Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis.The effect of metformin on survival of patients with pancreatic cancer: a meta-analysisEffect of Metformin Use on Survival in Resectable Pancreatic Cancer: A Single-Institution Experience and Review of the Literature.Impact of Metformin on Advanced Pancreatic Cancer Survival: Too Little, Too Late?Obesity and Cancer: An Angiogenic and Inflammatory Link.Selective Disruption of Respiratory Supercomplexes as a New Strategy to Suppress Her2high Breast Cancer.Diabetes drugs and the incidence of solid cancers: a survey of the current evidence.No association between metformin use and survival in patients with pancreatic cancer: An observational cohort study.Targeting Cancer Metabolism: Dietary and Pharmacologic Interventions.Combinational strategies of metformin and chemotherapy in cancers.Metformin and Prostate Cancer: a New Role for an Old Drug.Metformin in pancreatic cancer treatment: from clinical trials through basic research to biomarker quantification.Obesity and Cancer Mechanisms: Cancer Metabolism.Impact of Concurrent Medication Use on Pancreatic Cancer Survival-SEER-Medicare Analysis.Hyperglycaemia Induced by Novel Anticancer Agents: An Undesirable Complication or a Potential Therapeutic Opportunity?Effect of Metformin and Statin Use on Survival in Pancreatic Cancer Patients: a Systematic Literature Review and Meta-analysis.Intratumoral heterogeneity of the therapeutical response to gemcitabine and metformin.Metformin Use Is Associated with Improved Survival in Patients Undergoing Resection for Pancreatic Cancer.Metformin Inhibits Gemcitabine Induced Apoptosis in Pancreatic Cancer Cell Lines.Effects of metformin on survival outcomes of pancreatic cancer: a meta-analysis.Prognostic significance of anti-diabetic medications in pancreatic cancer: A meta-analysis.Repurposing Established Compounds to Target Pancreatic Cancer Stem Cells (CSCs).Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer.Metformin Decreases the Incidence of Pancreatic Ductal Adenocarcinoma Promoted by Diet-induced Obesity in the Conditional KrasG12D Mouse Model.Effects of metformin on survival outcomes of pancreatic cancer patients with diabetes: A meta-analysis.Evidence-based complementary treatment of pancreatic cancer: a review of adjunct therapies including paricalcitol, hydroxychloroquine, intravenous vitamin C, statins, metformin, curcumin, and aspirinMetformin and blood cancersDrug Repurposing of Metabolic Agents in Malignant Glioma
P2860
Q30234827-590D9F78-BA5F-4F6A-8255-B15E6FC5233CQ33648824-8EBEA1A4-0ABB-44B7-9170-45CB5307586EQ33919105-0DEC9269-E0F1-48B2-BB14-55F165992093Q35953756-F70E8EBE-74B1-4EBC-A7E4-A6C1D5704116Q36642870-F86DED8C-59CC-4ACB-9F7C-75A0F86CF746Q36759129-37E3FBB1-972B-498A-9E9B-2D15BD86DB85Q37550624-D31C4B1E-6DEF-498E-B059-7E716B096097Q38651175-5A148040-2F24-4794-BF98-0D954F261870Q38748916-D3151EE5-B1E0-4F1D-8082-3408385BAE25Q38792334-1351D282-11AB-4694-9115-99FC457868ACQ38818730-B9975E18-A43A-48F8-BD3B-916325181D9CQ38819039-2BC7AD39-A083-4C0B-A3E0-B416AC2FE411Q38829871-A8063994-A341-4FDD-A546-E7F6B23DF464Q39024765-5F8463D4-2863-459D-BC5C-EF430CC74D72Q39025087-4B6AC3B1-DC4B-4CE0-BB8C-786A03E3CC4AQ39040854-F0DC186E-485A-4353-B91D-89F47B3EC9A2Q39238333-C7FEFF12-DB1C-48E7-BB43-6C690FB711ABQ39529888-D55AFCFB-41E3-49F9-AA63-55A663FC3C77Q39714372-4AF24E0A-2EB6-4E84-B37E-A7568D81A7CCQ41395916-24640CF9-C160-4030-9269-859D198BE5CCQ41548205-9F331B70-314B-4650-9A36-BEFA8FFA9C09Q42244223-DA174E43-CF57-45AB-A692-035A09C43D48Q47117704-B7F74C69-5725-4014-AC45-5395380485A1Q50053806-5E85F9AA-205B-43F9-A8DF-1FA47BC24D97Q52590946-330C6127-3881-4A18-8726-4F0BE458727CQ53272010-AF0AB84B-9AF0-496B-9335-6FF5451BB8D1Q57176118-E8A43B24-3C39-4DBA-B654-70E5125FC342Q58699189-6352A487-6499-4E5A-817A-8823E6BBBBF5Q58738611-36931CBB-39EB-4B7F-B1F4-5B951E744C76
P2860
(Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
(Ir)relevance of Metformin Tre ...... el, Randomized Phase II Trial.
@en
(Ir)relevance of Metformin Tre ...... el, Randomized Phase II Trial.
@nl
type
label
(Ir)relevance of Metformin Tre ...... el, Randomized Phase II Trial.
@en
(Ir)relevance of Metformin Tre ...... el, Randomized Phase II Trial.
@nl
prefLabel
(Ir)relevance of Metformin Tre ...... el, Randomized Phase II Trial.
@en
(Ir)relevance of Metformin Tre ...... el, Randomized Phase II Trial.
@nl
P2093
P50
P1476
(Ir)relevance of Metformin Tre ...... el, Randomized Phase II Trial.
@en
P2093
Daniela Liberati
Domenica Ceraulo
Gaetano Di Terlizzi
Gianpaolo Balzano
Michele Reni
Paola Maggiora
Roberto Nicoletti
Stefano Cereda
Valeria Sordi
P304
P356
10.1158/1078-0432.CCR-15-1722
P407
P50
P577
2015-10-12T00:00:00Z